BioSpace News Archive

Business

Alcami Announces Manufacturing Agreement for Solasia’s Active Pharmaceutical Ingredient Darinaparsin

The company has finalized manufacturing and quality agreements with Solasia Pharma, K.K.

November 9, 2017
·
2 min read
BioForest

Super-resolution Photoacoustic Imaging Could Allow Scientists to Watch Blood Vessels With Improved Resolution, Published in the Optical Society

Researchers have reported an approach to photoacoustic imaging that offers vastly improved resolution, setting the stage for detailed in vivo imaging of deep tissue.

November 9, 2017
·
6 min read
Business

Trovagene Announces Third Quarter 2017 Company Highlights and Financial Results

Trovagene made significant progress in the third quarter to advance the clinical research of PCM-075 for solid and hematologic tumor cancers.

November 9, 2017
·
19 min read
Business

CASMED Reports Third-Quarter 2017 Financial Results

Net sales from continuing operations for the third quarter of 2017 were $4.5 million, compared with $5.0 million for the prior-year period.

November 9, 2017
·
10 min read
Business

Corium to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, November 16, 2017

Corium will host a conference call and live audio webcast at 5:00 p.m. Eastern time, 2:00 p.m. Pacific time to discuss its financial results and report on recent progress.

November 9, 2017
·
1 min read
Business

Sienna Biopharmaceuticals Reports Third Quarter 2017 Financial Results

Total operating expenses for the three months ended Sept. 30, 2017, were approximately $14.3 million.

November 9, 2017
·
1 min read
Business

Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Operational Highlights

$16.3 million cash and cash equivalents as of September 30, 2017 as compared to $27.3 million as of June 30, 2017.

November 9, 2017
·
11 min read
Business

SQI Diagnostics to Announce Fourth Quarter and Fiscal 2017 Results

President and CEO, Andrew Morris, along with Company management, will host a conference call on Friday, November 17, 2017 at 10:00 a.m. ET to review financial results and discuss business developments for the period.

November 9, 2017
·
2 min read
Decisions of Herantis Pharma Plc’s Extraordinary General Meeting of Shareholders

The Extraordinary General Meeting of Shareholders resolved to authorise the Board of Directors, as proposed by the Board of Directors, to decide on the issuance of shares.

November 9, 2017
·
2 min read
Business

PharMerica Reports Third Quarter 2017 Results

Revenues for the third quarter of 2017 were $595.1 million compared with $512.6 million for the third quarter of 2016.

November 9, 2017
·
17 min read